•  
You are here:

 

Dermatology

New Psoriasis Guidelines Expand Treatment Options (CME/CE)

E-mail Print PDF
Medical News:New Psoriasis Guidelines Expand Treatment Options - in Dermatology, Psoriasis from MedPage Today var omniture_zone = "home"; var omniture_ct = ""; var omniture_ugc = "0"; var source_name = "mpt"; var author = ""; var auth = "loggedout"; var app_name = "MedPageToday"; var page_id = ""; var omniture_event = "event5"; Omniture.Init(omniture_zone, omniture_ct, omniture_ugc, source_name,...

CDC Says Strange Skin Condition Not Infectious (CME/CE)

E-mail Print PDF

A mysterious condition in which cloth fibers or other materials are reported to emerge from the skin doesn't appear to be infectious, a CDC team said after studying a possible cluster of cases in northern California.

A wide range of tests turned up no single bacteria, mycobacteria, virus, or parasitic explanation for what is being called Morgellons, according to Mark L. Eberhard, of the...

Kids, Teens Ignore Sun Risks (CME/CE)

E-mail Print PDF
Most children and adolescents did not regularly use sunscreen despite reporting high rates of sunburn, data from a prospective cohort study showed. Half of a group of fifth-graders did not "often or always" use sunscreen when outdoors for prolonged periods of time. Follow-up interviews three years later showed that regular use of sunscreen had declined to 25%. For both surveys, a majority of the s...

Melanoma Drug"s Link to Second Cancers Explained (CME/CE)

E-mail Print PDF
The recently approved melanoma drug vemurafenib (Zelboraf) accelerates growth of nonmelanoma skin cancers but does not cause the secondary cancers, an international research team has concluded. In laboratory studies, the BRAF inhibitor vemurafenib stimulated mitogen-activated protein kinase (MAPK) signaling that led to increased proliferation of cells harboring RAS mutations, particularly...

Page 1 of 79

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »